Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial

Overview of attention for article published in Respiratory Research, December 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

blogs: 1 blog
policy: 1 policy source

twitter: 1 X user
facebook: 1 Facebook page

Citations

dimensions_citation: 154 Dimensions

Readers on

mendeley: 148 Mendeley
citeulike: 1 CiteULike

Summary Blogs Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 1 blog post.

Advances in respiratory medicine: discussions at the British Thoracic Society Winter meeting and COPD 2012

BioMed Central blog, 21 Dec 2012

Respiratory medicine is a main area of acute general medicine and for research funding agencies, which invest in large clinical…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.